Member Info for elrico

The rise came on the back of positive AxisBiotix estimated sales data I shared. I had nothing to do with OPTI. Why would it? https://lemminginvestor.substack.com/p/skinbiotherapeutics-plc-a8b

The significance of the update demonstrated sales were above where investors had expected.

I should add - the issues I have had with THG have nothing to do with OPTI. I've had similar issues with H&B and AxisBiotix. Sadly, THG poor customer service and poor logistics control set it apart.

I have been trialling Myprotein:
Impact diet lean - low sugar - brown sugar milky tea flavour
Impact diet lean - low sugar - Vanilla
Breakfast Smoothie - Banana & Strawberry

All contain LeanBiome - All 1KG £27.94 - £29.61

They work really well. However, THG's Myprotein site has wound me up like a clock. They double charged me by duplicating the order. Originally processed via the app, which crashed. I completed the order via the website. I then got a notification for the same order twice. I logged back into the site and cancelled the 2nd order. Job done, so I thought. Three days later, both orders arrived. I sent one back, and then the fun began! Seven weeks later, still no refund for the returned order after they acknowledged reciet four weeks late!!

It goes some way to explaining why THG SP is where it is! Pathetic customer service. Great product, but I will not be ordering again!

Ah, I see what you mean, Skid. It’s more likely due to investors interest building on the back of SweetBiotix hopes. Aqua posted an interesting link where bulk orders could be made.

Skid,

Can you be more specific with your statement? "who?" and what? "clearly were trading on non-public information." Or is this just a hunch, a conspiracy? I am not suggesting it doesn't happen, we all know it has happened, but OPTI?

Cheers.

I can share with you now I have confirmation from SOH and Sharescope. I will be conducting a Zoom interview with SOH on Tuesday. Later in the month, I will publish a broad-stroke human microbiome editorial featuring both OPTI and SBTX to be hosted on ShareScope, where I have a regular guest author slot. knowledge.sharescope.co.uk/author/elric-langton/

The hope is both SBTX and OPTI will be under the spotlight to a new large audience, which I believe is more extensive than SP.

I can share with you now I have confirmation from SOH and Sharescope. I will be conducting a Zoom interview with SOH on Tuesday. Later in the month, I will publish a broad-stroke human microbiome editorial featuring both OPTI and SBTX to be hosted on ShareScope, where I have a regular guest author slot. knowledge.sharescope.co.uk/author/elric-langton/

The hope is both SBTX and OPTI will be under the spotlight to a new large audience, which I believe is more extensive than SP.

There's no doubt a peer review paper on SweetBiotix is a significant milestone validating the science and functionality. This is exceptionally important in the food & beverage industry. In addition, it makes the promotion of SweetBiotix that much easier because it is the selling point that no other sugar products have.

Good find, Mol.

It looks like a wholesale site, similar to Alibaba.

It may have blown the doors off, but my fear is margin will be squeezed in an effort to reduce passing the costs onto the consumer. https://lemminginvestor.substack.com/p/itaconix-plc-2c2

lemming investor at ya hoo .com :)

If you have any issues you can email me lemming investor **********

I'd be surprised if SOH doesn't repeat the same during his interviews next week. I happen to be the first and felt it needed to be shared during Mike's update. The article is available FOC to all; you just need to register for limited premium access unless I've made a pig's ear of it. https://lemminginvestor.substack.com/

Martin,

They say all publicity is good publicity, and although I got slated for some of my comments about OPTI during the Twin Pete's podcast (for which I added some context - https://youtu.be/56-K3uBCGK0 ), I am aware some new members read what myself and Mike had to say on OPTI and bought. I know TW also remains positive; when has not? And as you say, SOH has been promoting the company. He told me yesterday he plans some interviews next week, one of which will be with me.

The SweetBiotix agreement also looks interesting, including the stats provided in Mike's update yesterday, which glossed over his moody update. And of course, OPTI is in Chicago - these events always attract new business, and with SweetBiotix now available, it could prove interesting.

Second editorial on OPTI today. https://lemminginvestor.substack.com/p/optibiotix-health-plc-05a By Mike Caine, not me, fat little Gimli. :)

Working link. https://lemminginvestor.substack.com/p/optibiotix-health-plc-294

SOH has sent me some clarification on the supply chain issues and chucked in some forecasts for the D2C side on a 3-5 years view. hTTps://lemminginvestor.substack.com/p/optibiotix-health-plc-294?r=kcv2o&s=w&utm_campaign=post&utm_medium=web

Indeed. I think DSM did a lot of work on stevia which reduced the bitterness using SweetBiotix IP. I can’t remember the details.

I’m guessing is responsible for consumer testing products outside the UK which contains SweetBiotix. If I’m correct, it offers hope of a consumer facing product much sooner than we May think. https://www.firmenich.com/taste-and-beyond

Firmenich Has completed its merger with established partner DSM, which has been instrumental in SweetBiotix, assuming my old grey has not failed me. It's too early to say how quickly revenues will build. It's undoubtedly very positive and welcome news for SweetBiotix.

Should read… iweb showed me how many POLb shares I have, but my ii account shows nothing other than I have a POLB asset with nil value and nil quantity. Essentially, iWeb were more efficiently working with the custodians of the shares.